First published 9/30/2026, 6:21:15 PM · Last updated 9/30/2026, 6:21:15 PM

Volumetric postmortem MRI of the medial temporal lobe in Alzheimer’s disease and related disorders: methodological advances and implications for in vivo biomarker development

Journal article reporting volumetric postmortem MRI of the medial temporal lobe in Alzheimer’s disease and related disorders, focusing on methodological advances and implications for in vivo biomarker development. Publisher listed as Elsevier BV and published 2026-09-01.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 2/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 4/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 7/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article presents methodological advances that the authors state have implications for developing in vivo biomarkers for Alzheimer’s disease.

Sources

Volumetric postmortem MRI of the medial temporal lobe in Alzheimer’s disease and related disorders: methodological advances and implications for in vivo biomarker development

Report an issue